Concepedia

Salvia Jain

SJ

Statistics

Publications

24

Citations

1.3K

H-Index

18

Active since

2011

Affiliations

Dana-Farber Cancer Institute(Current)

Beth Israel Deaconess Medical Center

Harvard University

Brigham and Women's Hospital

Massachusetts General Hospital

Salvia Jain is an author at Dana-Farber Cancer Institute specializing in oncology, medicine, and cancer immunotherapy.

Publications per year

2011–2024

24

Publications

24

MUC1-mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemia

Athalia R. Pyzer, Dina Stroopinsky, Hasan Rajabi et al. · Blood · 2017 · 192 citations · Full text

Medicine, Cancer Biology, Oncology +16

Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissions

Jacalyn Rosenblatt, Richard M. Stone, Lynne Uhl et al. · Science Translational Medicine · 2016 · 164 citations · Full text

Medicine, Immunology, Oncology +17

Preclinical Models of Cancer Therapy–Associated Cardiovascular Toxicity: A Scientific Statement From the American Heart Association

Aarti Asnani, Javid J. Moslehi, Bishow B. Adhikari et al. · Circulation Research · 2021 · 85 citations · Full text

Medicine, Cardiology, Oncology +16

CD163 versus CD68 in tumor associated macrophages of classical hodgkin lymphoma

Jonathan Harris, Salvia Jain, Qinghu Ren et al. · Diagnostic Pathology · 2012 · 80 citations · Full text

Medicine, Oncology, Pathology +17

Preclinical Pharmacologic Evaluation of Pralatrexate and Romidepsin Confirms Potent Synergy of the Combination in a Murine Model of Human T-cell Lymphoma

Salvia Jain, Xavier Jirau-Serrano, Kelly Zullo et al. · Clinical Cancer Research · 2015 · 77 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 24